End-of-day quote
Shenzhen S.E.
18:00:00 2024-05-16 EDT
|
5-day change
|
1st Jan Change
|
12.63
CNY
|
-0.32%
|
|
-2.17%
|
-38.18%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Capitalization
1 |
9,789
|
7,292
|
8,281
|
Enterprise Value (EV)
1 |
10,282
|
8,394
|
10,657
|
P/E ratio
|
80.5
x
|
31.6
x
|
61.9
x
|
Yield
|
0.3%
|
0.64%
|
0.24%
|
Capitalization / Revenue
|
1.84
x
|
0.93
x
|
0.9
x
|
EV / Revenue
|
1.93
x
|
1.07
x
|
1.16
x
|
EV / EBITDA
|
47.7
x
|
19.3
x
|
30.2
x
|
EV / FCF
|
106,372,740
x
|
52,801,198
x
|
194,245,615
x
|
FCF Yield
|
0%
|
0%
|
0%
|
Price to Book
|
5.18
x
|
3.49
x
|
3.85
x
|
Nbr of stocks (in thousands)
|
405,340
|
405,340
|
405,340
|
Reference price
2 |
24.15
|
17.99
|
20.43
|
Announcement Date
|
22-04-27
|
23-04-26
|
24-04-26
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,888
|
3,467
|
4,640
|
5,322
|
7,823
|
9,191
|
EBITDA
1 |
187.6
|
182.2
|
354.8
|
215.6
|
434.7
|
353
|
EBIT
1 |
172.6
|
153.6
|
318.8
|
173.6
|
381.8
|
292
|
Operating Margin
|
5.98%
|
4.43%
|
6.87%
|
3.26%
|
4.88%
|
3.18%
|
Earnings before Tax (EBT)
1 |
166.6
|
161.8
|
292.6
|
150.5
|
320.5
|
177.6
|
Net income
1 |
113.4
|
111.2
|
216.4
|
114.9
|
229.4
|
133.1
|
Net margin
|
3.93%
|
3.21%
|
4.66%
|
2.16%
|
2.93%
|
1.45%
|
EPS
2 |
0.3300
|
0.3000
|
0.5900
|
0.3000
|
0.5700
|
0.3300
|
Free Cash Flow
|
-
|
-85.51
|
149.1
|
96.66
|
159
|
54.86
|
FCF margin
|
-
|
-2.47%
|
3.21%
|
1.82%
|
2.03%
|
0.6%
|
FCF Conversion (EBITDA)
|
-
|
-
|
42.02%
|
44.83%
|
36.57%
|
15.54%
|
FCF Conversion (Net income)
|
-
|
-
|
68.89%
|
84.11%
|
69.29%
|
41.23%
|
Dividend per Share
|
-
|
-
|
0.1100
|
0.0730
|
0.1150
|
0.0500
|
Announcement Date
|
21-06-09
|
21-06-09
|
21-06-09
|
22-04-27
|
23-04-26
|
24-04-26
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
493
|
1,102
|
2,376
|
Net Cash position
1 |
528
|
338
|
456
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
2.285
x
|
2.534
x
|
6.73
x
|
Free Cash Flow
|
-
|
-85.5
|
149
|
96.7
|
159
|
54.9
|
ROE (net income / shareholders' equity)
|
-
|
8.49%
|
15.4%
|
6.64%
|
11.2%
|
6.05%
|
ROA (Net income/ Total Assets)
|
-
|
3.96%
|
7.22%
|
2.69%
|
3.71%
|
2.12%
|
Assets
1 |
-
|
2,810
|
2,996
|
4,279
|
6,185
|
6,269
|
Book Value Per Share
2 |
3.570
|
3.560
|
4.170
|
4.660
|
5.150
|
5.300
|
Cash Flow per Share
2 |
1.540
|
1.230
|
1.550
|
1.530
|
4.590
|
3.450
|
Capex
1 |
134
|
115
|
194
|
137
|
110
|
182
|
Capex / Sales
|
4.65%
|
3.32%
|
4.18%
|
2.57%
|
1.41%
|
1.98%
|
Announcement Date
|
21-06-09
|
21-06-09
|
21-06-09
|
22-04-27
|
23-04-26
|
24-04-26
|
|
1st Jan change
|
Capi.
|
---|
| -38.18% | 709M | | -13.36% | 3.6B | | -11.41% | 3.02B | | +12.84% | 2.84B | | +16.93% | 2.83B | | -2.81% | 1.9B | | +11.42% | 1.41B | | -20.60% | 970M | | -0.53% | 465M | | +6.33% | 405M |
Retail - Drugs with Grocery
|